Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 371 studies with search of: | Open Studies | "Myelodysplastic Syndromes" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
|
||||
2 | Recruiting |
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
|
||||
3 | Recruiting |
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
|
||||
4 | Recruiting |
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
||||
5 | Recruiting |
Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
|
||||
6 | Not yet recruiting |
Everolimus in Treating Patients With Myelodysplastic Syndromes
|
||||
7 | Recruiting |
PXD101 in Treating Patients With Myelodysplastic Syndromes
|
||||
8 | Recruiting |
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
|
||||
9 | Recruiting |
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
|
||||
10 | Recruiting |
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
|
||||
11 | Recruiting |
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
|
||||
12 | Recruiting |
Iodine I 131 Monoclonal Antibody BC8, Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
||||
13 | Recruiting |
17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
|
||||
14 | Recruiting |
Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
|
||||
15 | Recruiting |
A Dose Confirmation Study of Oral Clofarabine for Previously Treated Adult Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS)
|
||||
16 | Recruiting |
Alemtuzumab and Cyclosporine in Treating Patients With Myelodysplastic Syndromes
|
||||
17 | Recruiting |
DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
||||
18 | Not yet recruiting |
Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
|
||||
19 | Recruiting |
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
|
||||
20 | Recruiting |
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
|
Previous Page | Studies Shown (1-20) | Next (21-40) |